anti-IGF-1 ribozymes (Ribozyme)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameanti-IGF-1 ribozymes (Ribozyme)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionInsulin-like growth factor I inhibitors

TargetsInsulin-like growth factor I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSirna Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSirna Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A